5Rangarajan A,Hong SJ,Gifford A,et al.Species-and cell type-specific requirements for cellular transformation. Cancer Cell . 2004
6Arroyo JD,Hahn WC.Involvement of PP2A in viral and cellular transformation. Oncegene . 2005
7Qu W,Li W,Wei L,et al.CIP2A is overexpressed in esophageal squamous cell carcinoma. Medical Oncology . 2010
8Chen KF,Liu CY,Lin YC,et al.CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Oncegene . 2010
9Casiano CA,Mediavilla-Varela M,Tan EM.Tumor-associated antigen arrays for the serological diagnosis of cancer. Molecular and Cellular Proteomics . 2006
10Vaarala MH,Visnen MR,Ristimki A.CIP2A expression is increased in prostate cancer. Journal of Experimental and Clinical Cancer Research . 2010
6Mumby M. PP2A: unveiling a reluctant tumor suppressor. Cell 2007; 130:21-24.
7Janssens v, Goris J, Van Hoof C. PP2A: the expected tumor suppressor. Curr Opin Genet Dev 2005; 15: 34-41.
8Junttila MR, Puustinen P, Niemela M, Ahola R, Arnold H, Bottzauw T, Ala-aho R, Nielsen C,Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grenman R, Kast J, Kallunki T, Sears R, Kahari VM, Westermarck J. CIP2A inhibits PP2A in human malignancies. Cell 2007; 130:51-62.
9Nagase T, Kikuno R, Ohara O. Prediction of the coding sequences of unidentified human genes. ⅩⅫ. The complete sequences of 50 new cDNA clones which code for large proteins. DNA Res 2001; 8:319-327.
10Soo Hoo L, Zhang JY, Chan EK. Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene 2002; 21:5006-5015.
1Yu HC, Chen H J, Chang YL, et al. Inhibition of cip2a de- termines erlotinib-induced apoptosis in hepatocellular car- cinoma [J]. Biochem Pharmacol, 2013,85 (3) : 356-366.
2Yu G, Liu G, Dong J, et al. Clinical implications of cip2a protein expression in breast cancer [J]. Med Oncol,2013, 30(2) :524.
3Yi F, Ni W, Liu W, et al. Expression and biological role of cip2a in human astrocytoma [J]. Mol Med Rep,2013,7 (5) : 1376-1380.
4Xue Y,Wu G,Wang X,et al. Cip2A is a predictor of sur- vival and a novel therapeutic target in bladder urothelial cell carcinoma [J]. Med Oncol, 2013,30(1 ) :406.
5Xu P,Xu XL,Huang Q,et al. Cip2a with survivin protein expressions in human non-small-cell lung cancer corre- lates with prognosis [J]. Med Oncol, 2012,29 (3) : 1643- 1647.
6Hanahan D,Weinberg R A. The hallmarks of cancer[J].Cell,2000,(01):57-70.
7Zhao J J,Roberts T M,Hahn W C. Functional genetics and experimental models of human cancer[J].Trends in Molecular Medicine,2004,(07):344-350.
8Mumby M. PP2A:unveiling a reluctant tumor suppressor[J].Cell,2007,(01):21-24.
9Junttila M R,Puustinen P,Niemel M. CIP2A inhibits PP2A in human malignancies[J].Cell,2007,(01):51-62.doi:10.1016/j.cell.2007.04.044.
10Khanna A,Bckelman C,Hemmes A. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer[J].Journal of the National Cancer Institute,2009,(11):793-805.
